Quick Takeaways
- David Patience has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,169,176.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow David Patience and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TLSI, TLSIW | TriSalus Life Sciences, Inc. | Chief Financial Officer | $1,101,493 | +$14,994 | +1.4% | 23 Feb 2026 |
| AXDX | Accelerate Diagnostics, Inc | Chief Financial Officer | $67,683 | 01 Apr 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|